Related by context. All words. (Click for frequent words.) 78 Antiviral Activity 74 Tolerability 74 Oral Fingolimod 73 Pharmacokinetics PK 73 Long Term Efficacy 73 Vitro Activity 73 Pharmacokinetic Study 72 See CLINICAL PHARMACOLOGY 72 Potent Antiviral Activity 72 Antitumor 72 Clinical Outcome 72 Pooled Analysis 72 Clinical Trial Results 71 Dendritic Cells 71 Quadrivalent 71 Antitumor Activity 71 Study Evaluating 71 Universal Flu Vaccine 71 Peginterferon Alfa 2a 71 Parathyroid Hormone 71 Rotavirus Vaccine 71 Single Dose 71 Placebo Controlled Trial 71 Pandemic Influenza Vaccine 70 Demonstrates Potent 70 Shows Promising 70 Dose Escalation 70 Immune Responses 70 Treating Chronic 70 JAK Inhibitor 70 Anti Tumor 70 Chronic Hepatitis C 70 Drug Candidate 70 Anti Tumor Activity 70 Inflammatory Arthritis 70 Fungal Infections 70 Prolongs Survival 70 Phase 2b Clinical Trial 70 Genotypes 70 Relapsing Multiple Sclerosis 70 Randomized Double blind 70 Adjuvanted 69 Chemokine Receptor 69 Kinase Inhibitor 69 Sustained Efficacy 69 Autologous Stem Cell Transplantation 69 Solid Tumors 69 Vaccine Adjuvant 69 Demonstrates Efficacy 69 Hepatocellular Carcinoma 69 Orally Active 69 Recombinant Human 69 Seasonal Influenza Vaccine 69 Pivotal Phase III 69 Peginterferon 69 RNAi Therapeutic 69 Antiviral Therapy 69 Randomized Clinical Trials 69 Preclinical Study 69 ara C 69 Phase IIb Trial 69 Vaccine Candidate 69 Pharmacokinetic PK 69 Clinical Efficacy 69 First Patient Dosed 69 Meta Analysis 69 Kidney Function 69 Pneumococcal Vaccine 69 Hepatitis B Virus 68 Cytotoxicity 68 Tolerability Study 68 Crit Rev 68 Double Blind Placebo 68 Atopic Dermatitis 68 Lupus Drug 68 Controlled Study 68 Monoclonal Antibody 68 Safety Tolerability 68 Pharmacodynamics 68 Shows Efficacy 68 Pneumococcal Conjugate Vaccine 68 Tumor Response 68 IND Application 68 Oral Insulin 68 Nilotinib 68 Anticancer Activity 68 Well Tolerated 68 Valortim R 68 Adjuvant Treatment 68 Controlled Trial 68 Live Attenuated 68 Double Blind Randomized 68 Hematological Cancers 68 Investigational Agent 68 Preclinical Models 68 Dendritic Cell 68 Complicated Skin 68 Chronic Hepatitis B 68 Haemophilus b Conjugate 68 Severe Sepsis 68 Experimental Vaccine 68 Randomized Phase 68 Demonstrates Positive 68 Nasal Powder 68 Attenuates 68 reactogenicity 68 Dose Response 67 Phase III Clinical Trial 67 Anti Inflammatory Drug 67 Protease Inhibitor 67 Hepatitis B Vaccine 67 II Clinical Trial 67 Meets Primary Endpoint 67 Valopicitabine 67 Randomized Double Blind 67 Demonstrates Statistically Significant 67 Investigational Compound 67 Tezampanel 67 Mucosal 67 Adenoviral 67 Systemic Delivery 67 Interferon Beta 67 Novel Antibiotic 67 Combination Vaccine 67 Protease Inhibitors 67 Novel Oral 67 Somatostatin 67 hemagglutination inhibition HAI 67 Randomized Study 67 Treatment Naïve 67 Influenza Vaccine 67 Pharmacokinetics 67 Unfractionated Heparin 67 Breast Cancer Recurrence 67 Immunogenic 67 Phase 2b Study 67 Prospective Randomized 67 Plus Ribavirin 67 Pharmacokinetic 67 HCV Protease Inhibitor 67 Polymerase Inhibitor 67 Drug Resistant 67 Previously Treated 67 Demonstrates Significant 67 Intradermal 67 Hypertensive Patients 67 Small Molecule 67 Demonstrated Significant 67 Pharmacodynamic 67 Anticancer Drugs 67 Prophylactic Treatment 67 NDA Submission 67 Renal Cell Carcinoma 67 Virus Infection 67 Multimeric 67 Quantitation 67 Hsp# Inhibitor 67 Combination REOLYSIN R 67 Placebo Controlled Study 67 Improves Outcomes 67 Treatment Naive Patients 67 Randomized Controlled Trials 67 Disease Progression 67 Adjuvant Chemotherapy 67 Hepatitis C Genotype 67 Late Breaker 67 PEG IFN 67 Novel Inhibitor 67 Liposomal 67 Pediatric Patients 67 Phase IIb Clinical Trial 66 Protein Expression 66 Hormone Refractory Prostate Cancer 66 Transdermal Patch 66 Phase 2a Trial 66 Phase IIa Clinical Trial 66 Advanced Melanoma 66 Patients Receiving 66 Melphalan 66 Receptor Agonist 66 HCV Genotype 66 Pivotal Phase 66 Virologic 66 Infected Patients 66 Inactivated 66 Telbivudine 66 Mouse Model 66 Presents Preclinical Data 66 Benign Prostatic Hyperplasia 66 Relapsed Refractory 66 Nitazoxanide 66 Rheumatoid Arthritis Patients 66 Plasmid DNA 66 Hepatotoxicity 66 Hepatitis C Infection 66 Survival Benefit 66 Influenza Virus 66 Pandemic Flu Vaccine 66 Combination Therapy 66 Aliskiren 66 Tyrosine Kinase Inhibitor 66 Serious Infections 66 Conjugate Vaccine 66 Completes Patient Enrollment 66 Patients Treated With 66 Adjunctive Therapy 66 Pivotal Study 66 Phase 2b Trial 66 surface antigen HBsAg 66 Progenitor Cells 66 Trial Evaluating 66 Topical Treatment 66 ISTODAX ® 66 Therapeutic Efficacy 66 Interferon Gamma 66 Pafuramidine 66 Prognostic Value 66 Insulin Glargine 66 Kidney Transplant Patients 66 Glatiramer Acetate 66 Dose Ranging Study 66 Immunotherapeutic 66 Colorectal Cancer Patients 66 Respiratory Virus 66 Investigational Treatment 66 Preclinical Data 66 Proves Effective 66 Severe Asthma 66 Postmenopausal Women 66 Nucleoside 66 Antiviral Drugs 66 Overactive Bladder 66 Initiated Phase 66 Phase III Trial 66 Estrogen Receptor 66 FDA Okays 66 Advanced Renal Cell 66 Inflammatory Markers 66 Acute Ischemic Stroke 66 Respiratory Syncytial Virus 66 Immunomodulatory 66 Premature Infants 66 Cancer Vaccines 66 Appears Safe 66 Shows Promise Against 66 Interferon Alpha 66 solithromycin 66 Follicular Lymphoma 66 IIa Clinical Trial 66 Efficacy Trial 66 Improves Survival 66 Multiple Myeloma Patients 66 Vaccine Adjuvants 66 Dapagliflozin 66 Fulvestrant 66 Combination Treatment 66 HDAC Inhibitor 66 Diabetic Nephropathy 66 7 valent Conjugate 66 Human Monoclonal Antibodies 66 Present Preclinical Data 65 Epidermal Growth Factor Receptor 65 Hepatitis C Virus 65 Phase III Clinical Trials 65 Randomized Clinical Trial 65 Combo Therapy 65 Poster Presentation 65 Systematic Review 65 Capsules CII 65 Adenoma 65 Synthetic Peptide 65 Immunosuppression 65 Aurora Kinase 65 Monotherapy 65 Oritavancin 65 Improved Survival 65 Regimens 65 Bosutinib 65 Recurrent Breast Cancer 65 Gene Mutation 65 Erectile Dysfunction Drug 65 Immune Mediated 65 Sipuleucel T 65 Myelodysplastic Syndromes 65 tigecycline 65 Non Inferiority 65 Chronic Myeloid Leukemia 65 Novel Mechanism 65 Fracture Risk 65 BAL# [002] 65 Allogeneic 65 Humanized Anti 65 Metastatic Colorectal Cancer 65 Cardiac Function 65 Phospholipase A2 65 preclinical efficacy 65 Tigecycline 65 Targeted Therapy 65 Adalimumab 65 Transdermal Delivery 65 Gastric Cancer 65 Files IND 65 Randomized Double Blind Placebo 65 Metastatic Renal Cell Carcinoma 65 Newly Diagnosed Multiple Myeloma 65 Psoriasis Drug 65 Tumor Targeting 65 Leukemias 65 Treatment Regimen 65 Prostate Cancer Vaccine 65 Cardiotoxicity 65 Therapeutic Vaccine 65 Lipid Levels 65 Novel Therapies 65 Statistically Significant 65 FDA Clears 65 Denufosol 65 Dasatinib 65 Adefovir 65 Preclinical Efficacy 65 Invasive Fungal Infections 65 Phase 2a Clinical Trial 65 PRN FDA Approves 65 Bone Mineral Density 65 Bare Metal Stent 65 Novel Method 65 FDA Approvals 65 Antifungals 65 Oral Cavity 65 Medoxomil 65 Initiate Clinical Trial 65 Metastatic Melanoma 65 Smooth Muscle 65 Elagolix 65 Peginterferon Alfa 2b 65 Histologic 65 Clinical Trial Data 65 Intravenous Immunoglobulin 65 Sirolimus Eluting Stent 65 Improve Survival 65 Novel Therapeutic 65 Osteoporosis Treatment 65 Viral Infections 65 Brain Metastases 65 Epilepsy Drug 65 Daptomycin 65 MF# adjuvanted 65 Novel Small Molecule 65 Effectively Treats 65 Advanced Colorectal Cancer 65 Presents Positive 65 Aortic Stenosis 65 Nicotine Vaccine 65 Universal Influenza Vaccine 65 Gout Drug 65 Nebulized 65 Venous Thromboembolism 65 Tiotropium 65 Influenza Vaccines 65 Genital Warts 65 Randomized Controlled 65 Mimetics 65 Blood Pressure Drug 65 Clostridium difficile Infection 65 Rotavirus Vaccines 65 Skeletal Muscle 65 Desvenlafaxine Succinate 65 DermaVir Patch 65 Uric Acid 65 Viral Load 64 Topical Gel 64 Chemotherapeutic Agents 64 Bioequivalence 64 Bioavailability 64 Ranolazine 64 Lymphocytic 64 Cyclooxygenase 2 64 Cholesterol Lowering Drug 64 Bazedoxifene 64 Confirmatory Phase 64 immunogenicity 64 Diagnostic Tests 64 Naive Patients 64 BioSante Pharmaceuticals Reports 64 Urinary Incontinence 64 Therapeutic Antibody 64 live attenuated influenza 64 Invasive Pneumococcal Disease 64 Toxoid 64 Thiovir 64 Inhibits 64 Cytotoxic 64 Multicenter Phase 64 SPRYCEL ® 64 Elderly Patients 64 Completes Enrollment 64 Myeloma Patients 64 MenC 64 Investigational Drug 64 Submits NDA 64 valent pneumococcal conjugate vaccine 64 Skin Lesions 64 STELARA TM 64 Viral Suppression 64 Therapeutic Vaccines 64 Sustained Release 64 Pegylated Liposomal Doxorubicin 64 Treatment Experienced 64 Observational Studies 64 Intravenous Formulation 64 Subgroup Analysis 64 Lanthanum Carbonate 64 PROSTASCINT R 64 Mylan Receives Approval 64 Metastatic Prostate Cancer 64 Live Attenuated Influenza Vaccine 64 Decitabine 64 Blind Placebo Controlled Trial 64 Mg Usa 64 Hypercholesterolemia 64 Malignant Melanoma 64 Pegylated Interferon 64 Knee Osteoarthritis 64 Rheumatoid Arthritis Drug 64 Septic Shock 64 Novel Vaccine 64 Epratuzumab 64 Myocardial Perfusion Imaging 64 Smallpox Vaccine 64 Neoadjuvant Chemotherapy 64 Epitopes 64 quadrivalent HPV vaccine 64 Gastrointestinal Stromal Tumors 64 Isavuconazole 64 Streptococcus agalactiae 64 See WARNINGS 64 Blood Pressure Lowering 64 Immunohistochemical 64 Critically Ill Patients 64 Reverse Transcriptase 64 PRTX 64 Relapsing Remitting Multiple Sclerosis 64 Antigen Specific 64 Localized Prostate Cancer 64 Stent Restenosis 64 Cognitive Impairment 64 Oligonucleotides 64 Therapeutic Effects 64 Tuberculosis Vaccine 64 Pandemic Influenza Vaccines 64 Percutaneous Tibial Nerve Stimulation 64 alfa 2a 64 Malaria Vaccine 64 von Willebrand Factor 64 Secondary Hyperparathyroidism 64 Potent Anti 64 Dose Escalation Study 64 Anthrax Toxin 64 Preterm Delivery 64 Reductase 64 GelVac TM 64 Endovascular Treatment 64 C Reactive Protein 64 Data Suggest 64 Cethromycin 64 Beneficial Effects 64 Amniotic Fluid 64 methicillin susceptible Staphylococcus aureus 64 Cardiovascular Outcomes 64 Tipranavir 64 Bacteremia 64 SABCS 64 Conjugate 64 highly immunogenic 64 Treated Patients 64 Anticoagulant 64 Drug Shows Promise 64 Predict Risk 64 Inflammatory Diseases 64 Lymphoid 64 Safinamide 64 Non Responders 64 Molecular Mechanism 64 Antigens 64 Demonstrate Significant 64 Vildagliptin 64 Monoclonal 64 MenACWY 64 Fibrinogen 64 Vaccine Diphtheria CRM# Protein 64 Nymox NX 64 Watchful Waiting 64 Pivotal Trial 64 Prostatic 64 Aflibercept 64 Clinical Evaluation 64 Bavituximab 64 Therapeutic Potential 64 Platelet Function 64 Monocytes 64 humanized monoclonal 64 Gram Positive 64 seroprotection 64 Genes Involved 64 Adjuvant Therapy 64 Dengue Virus 64 Randomized Trials 64 Renal Cancer 64 antiviral efficacy 64 Initiate Phase 64 Lung Cancer Drug 64 Cerebrospinal Fluid 64 LENALIDOMIDE 63 Patent Covering 63 Low Dose 63 Cell Lymphoma 63 Partial Onset Seizures 63 Is Well Tolerated 63 ceftazidime 63 Inflammatory Disease 63 administered intramuscularly 63 Long Term Outcomes 63 Mycophenolate Mofetil 63 Efficacy Results 63 Intranasal 63 Traficet EN 63 Tumor Cell 63 Platelet Inhibition 63 Immunoglobulin 63 Inhaled Nitric Oxide 63 Bare Metal Stents 63 Anticancer Drug 63 Inhaled Corticosteroids 63 Blinatumomab 63 Unresectable 63 Initiates Clinical Trial 63 Efficacy Study 63 Lung Cancer Trial 63 J Pediatr 63 Antiviral 63 Demonstrates Sustained 63 Chronic Lymphocytic Leukemia 63 ritonavir boosted 63 Seasonal Influenza 63 AnaSpec Introduces 63 Respiratory Distress 63 Pemphigus Vulgaris 63 Tocilizumab 63 Levofloxacin 63 Receives Orphan Drug Designation 63 Pegylated 63 Postmarketing 63 Patient Enrollment 63 Initiates Clinical 63 ORENCIA ® 63 Multicenter Trial 63 Nanoemulsion 63 Autoimmune Disease 63 Diabetic Neuropathy 63 Genetic Variation 63 Randomized Placebo Controlled Trial 63 Treatment Reduces 63 Poster Presentations 63 INCB# [003] 63 Oral Mucositis 63 Clinically Significant 63 Acellular Pertussis 63 Molecular Diagnostic 63 Intravitreal 63 Lung Cancer Survival 63 Asthma Treatment 63 Angiogenic 63 FDA Accepts 63 Phase 1b Clinical Trial 63 Prognostic Factors 63 pharmacokinetics PK 63 Efficacious 63 serogroup B 63 Fast Track Status 63 REG2 63 Prophylaxis 63 Contrast Agents 63 Ovarian Cancers 63 RNAi Therapeutics 63 Sanofi Pasteur Fluzone 63 MenACWY CRM 63 FDA Clearance 63 Significantly Improves 63 Interferon beta 1a 63 Sapacitabine 63 Renal Function 63 invasive candidiasis 63 TYGACIL 63 Receives Orphan Drug 63 HER2 Positive 63 Fondaparinux 63 Radezolid 63 Systemic Sclerosis 63 Multicenter Study 63 Sangamo BioSciences Announces 63 Tumor Progression 63 Advanced Prostate Cancer 63 FDA APPROVES 63 Contrast Agent 63 vapreotide acetate 63 Circulating Tumor Cells 63 Preclinical Evaluation 63 Test Detects 63 IND Filing 63 Vertebral Fracture 63 Abstract Number 63 CYP#A# CYP#D# 63 Japanese Encephalitis vaccine 63 Antibody Discovery 63 Natalizumab 63 Allergic Rhinitis 63 Vivo Efficacy 63 Cognitive Function 63 Study Showed 63 Infectivity 63 Factor Receptor 63 Cytogenetic 63 Capecitabine 63 Prostate Cancer Patients 63 Thromboembolism 63 Phase III Trials 63 Lubiprostone 63 Pre Cancerous 63 Dalbavancin 63 TRANSFORMS 63 Eluting Stent 63 Faropenem 63 Hemodialysis Patients 63 Modified Vaccinia Ankara 63 Novel Treatments 63 novel VDA molecule 63 Drug Combo 63 Clinical Relevance 63 Inhalation Solution 63 Clinical Trial Evaluating 63 PENNVAX B 63 Malignancies 63 Beta Blocker 63 Potent Inhibitor 63 Genetic Tests 63 Targeted Therapies 63 Randomised 63 Kidney Transplant Recipients 63 Achieves Primary Endpoint 63 #th Annual Interscience 63 Therapy Improves 63 Fidaxomicin 63 Modulates 63 Randomized Phase II 63 Expanded Indication 63 MYCAMINE 63 Eculizumab 63 Oncolytic 63 posaconazole 63 Montelukast 63 Thyroid Hormone 63 C1 Inhibitor 63 Successfully Completes Phase 63 Showed Significant 63 Arch Neurol 63 Mg Uk 63 Posaconazole 63 Breast Cancer Cells 63 Treatment Naive HIV 63 Human Monoclonal Antibody 63 Radiation Induced 63 Digene HPV Test 63 Etanercept 63 Vaginal Gel 63 Ozarelix 63 Betaferon R 63 Activator CK # 63 Efficacy 63 Cancer Res 63 Vaccine Protects Against 63 lexidronam injection 63 Nonclinical 63 Ann Rheum Dis 63 Dry Powder Inhalers 63 Short Stature 63 Myelofibrosis 63 Advanced Pancreatic Cancer 63 HPV-#/# 63 Endothelial Cells 63 GRAS Status 63 Atypical Hemolytic Uremic Syndrome 63 Chemotherapy Improves 63 Fluconazole 63 Carbidopa Levodopa 63 Intravesical 63 CERVARIX 63 Patients Suffering 63 Glufosfamide 63 Genotype 63 Valopicitabine NM# 63 J Allergy Clin 63 Pioglitazone 63 Significantly Improved 63 Diabetic Foot Ulcer 63 PEGylated Fab fragment 63 Bacterial Infection 63 Androgen Deprivation Therapy 63 Protease 63 Protein Involved 63 Epoetin Alfa 63 samarium Sm 63 Immune Cell 63 Antiplatelet Therapy 63 Trodusquemine MSI 63 Oral Fluid 63 Aptamer 63 IN PATIENTS WITH 63 Osteoporosis Drug 63 Treatment Regimens 63 Xenografts 62 Genital Herpes 62 Antibiotic Treatment 62 Gynecol Oncol 62 Liver Toxicity 62 Hematological 62 Schizophrenia Treatment 62 Induces 62 Darbepoetin Alfa 62 Pivotal Trials 62 BioElectronics Announces 62 Avian Flu Vaccine 62 Aggressive Prostate Cancer 62 Antiangiogenic 62 Signaling Pathway 62 Stent Thrombosis 62 Prolonged Survival 62 SynCon ™ DNA 62 Topline Results 62 Malignant Glioma 62 Treatment Resistant 62 Patency 62 Veterinary Vaccines 62 Iron Deficiency 62 Drug Formulation 62 B Cell Lymphoma 62 Respiratory Syncytial Virus RSV 62 Ondansetron Injection USP 62 Alkaline Phosphatase 62 Maleate 62 Budesonide 62 Potentially Fatal 62 Subtypes 62 Antifungal 62 CLINICAL PHARMACOLOGY 62 Replacement Therapy 62 adalimumab Humira 62 Suppl. 62 Mutation Detection 62 Oxidative Stress 62 Interferon alfa 62 Autoantibodies 62 Cancer Therapies 62 Endometrial Cancer 62 Hormone Receptor Positive 62 PDUFA Date 62 Neuroprotective Effects 62 Cell Proliferation 62 Migraine Drug 62 Cell Adhesion 62 DermaVir 62 Diabetic Patients 62 Cannabinoid 62 Diabetic Neuropathic Pain 62 Oral Presentations 62 Hepatic 62 Immunostimulatory 62 Epilepsy Drugs 62 Ovarian Cancer Patients 62 Secretase 62 LEVAQUIN ® 62 Assay Kits 62 Oral Formulation 62 Treatment Naive 62 Confirms Efficacy 62 Pharmacokinetic Pharmacodynamic 62 Sirolimus Eluting 62 LAB CGRP 62 Azacitidine 62 Proliferative 62 Phase III Pivotal Trial 62 alpha 2a 62 Iron Overload 62 J Clin 62 Tetanus Toxoids 62 Functional Outcomes 62 Sandostatin R 62 Estrogen Therapy 62 Golimumab 62 Hematologic 62 TB Vaccine 62 pharmacokinetic PK 62 TNF Blockers 62 Randomized Controlled Trial 62 Vicriviroc 62 TO AVOID PREGNANCY WHILE 62 Cytomegalovirus 62 Inactivation 62 Suicidality 62 Lowers Risk 62 QLT# 62 Growth Hormone Deficiency 62 Xelox 62 oral prodrug 62 MERIT ES 62 Breast Density 62 Luminex xTAG 62 Ankara MVA 62 liposome injection 62 Oral Interferon 62 Receptor Antagonist 62 limiting toxicity DLT 62 Medullary Thyroid Cancer 62 Indomethacin 62 Cytochrome P# 62 Receives Approvable Letter 62 Kahalalide F 62 Thrombotic 62 Certolizumab 62 Antiviral Drug 62 Telithromycin 62 Shingles Vaccine 62 Interferon alpha 2b 62 Interferon Alfa 62 Increased Mortality 62 Cytotoxic T 62 Anti Inflammatory 62 Antibacterials 62 REYATAZ R 62 Placebo Controlled 62 FDA Approvable Letter 62 Immunomedics Announces 62 relapsed MM 62 Fluticasone 62 pharmacodynamic parameters 62 Glucocorticoid 62 Oropharyngeal 62 Palonosetron 62 virosome 62 Refractory Hodgkin Lymphoma 62 Mouse Models 62 replicon 62 Preterm Infants 62 lucinactant 62 Gene Expression Analysis 62 Hospital Acquired Pneumonia 62 Enoxaparin 62 Analytical Tool 62 Dual Antiplatelet Therapy 62 Endothelial 62 atazanavir sulfate 62 Predict Response 62 Autoimmune Disorders 62 Monoclonal Antibodies 62 mg kg BID 62 Vaccine Prevents 62 Bicalutamide 62 D Dimer 62 Secretion 62 Moxifloxacin 62 Darunavir 62 Develops Novel 62 Biomarker Study 62 Newly Diagnosed 62 Pivotal Clinical Trial 62 AASLD Meeting 62 Chronic Heart Failure 62 Breast Tumors 62 Extended Release 62 Atomoxetine 62 Hepatic Encephalopathy 62 Phase Ib Clinical Trial 62 Vaccine Trial 62 GOUT 62 Vaxfectin ® 62 Bile Acid 62 Carfilzomib 62 GARDASIL ® 62 Rabies Vaccine 62 Clin Oncol 62 Lenalidomide 62 Virulence 62 Patients Undergoing 62 Skin Irritation 62 Copegus ribavirin 62 Anthracycline 62 Roche COBAS 62 By JENNIFER LEARN 62 Initiates Phase II 62 viral kinetics 62 Prostate Tumors 62 Respiratory Viruses 62 Reports Preclinical Data 62 Patients Treated 62 qualitative serum 62 Prospective Randomized Trial 62 Carotid Stenting 62 Bacterial Vaginosis 62 Heart Failure Patients 62 Non inferiority 62 Cervical Dysplasia 62 Soft Tissue Sarcoma 62 Omacetaxine 62 attenuated strain 62 Invasive Breast Cancer 62 Murine Model 62 Tumor Suppressor Gene 62 Pemetrexed 62 Cervista HPV HR 62 Prospective Multicenter 62 Left Ventricular 62 Drug Regimen 62 Pulmonary Arterial Hypertension 62 Integrase Inhibitor 62 sunitinib Sutent ® 62 Radical Prostatectomy 62 Secretory 62 Cutaneous T 62 #:#-# [035] 62 Pegasys ® 62 Study Casts Doubt 62 Cholesterol Drugs 62 Drug Prevents 62 Metabolites 62 Maribavir 62 fosbretabulin 62 Begin Clinical Trials 62 candidates Azedra 62 tolerability profiles 62 Protein Interactions 62 pan HDAC inhibitor 62 Differential Diagnosis 62 non nucleoside inhibitor 62 Receptor Antagonists 62 Birth Weight 62 Osteoarthritis Pain 62 Vitamin D Supplementation 62 Generalized Anxiety Disorder 62 Kinase Inhibitors 62 Lyophilized 62 Innate Immune 62 Chronic HCV 62 Respiratory Infections 62 Confirmatory 62 Resistant Hypertension 62 Commonly Used 62 Abdominal Fat 62 Symptom Relief 62 Infectious Disease Testing 62 liposomal amphotericin B 62 Am J Clin 62 AZT 3TC 62 Multicenter Randomized 62 Immunosuppressant 62 Anti CD# Antibody 62 Apoptotic 62 Ecallantide 62 Stakeholder Opinions 62 Commences Phase 62 Squamous Cell Carcinoma 61 Hepatitis C Patients 61 Liver Injury 61 Mesylate 61 Serologic 61 piroxicam 61 Bortezomib 61 Linezolid 61 Slow Progression 61 Prodrugs 61 Rapid Detection 61 Antibiotic Resistant 61 NSABP B 61 Bivalirudin 61 Tesamorelin 61 Microspheres 61 Neuroprotection 61 JAK2 Inhibitor 61 Autoimmune Diseases 61 Peripheral Blood 61 Pneumococcal Disease 61 Bowel Disease 61 Fecal Incontinence 61 TAXUS ATLAS 61 Mutational 61 Treatment Shows Promise 61 CEQ# 61 Neuroendocrine Tumors 61 Pharmacokinetic Profile 61 Neutralizing Antibodies 61 Alocrest